nach oben

Familial Cancer

Erschienen in:

14.03.2017 | Original Article

Supporting disclosure of genetic information to family members: professional practice and timelines in cancer genetics

verfasst von: Benjamin Derbez, Antoine de Pauw, Dominique Stoppa-Lyonnet, Sandrine de Montgolfier

Erschienen in: Familial Cancer | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Disclosure of genetic information within families is one of the longstanding questions under scrutiny in the field of genetics. Most of the probands entrusted with family disclosure succeed in this task, but there are still many problematic cases where it proves difficult. How can professionals help probands disclose this information? What levers can they activate to foster the diffusion of genetic information within families? In the context of a new legal framework concerning this question in France, this paper offers a comprehensive view of the process of genetic counselling in a cancer genetics department. Based on an ethnographic study, it focuses on the interactions between professionals and probands during each step of the testing procedures in order to identify key times when the issue can be addressed. The results show that the question of family disclosure needs to be addressed before, during and after the test. Greater awareness of this continuum among professionals could help them foster family disclosure by supporting the probands at each stage of the testing procedure

Nur mit Berechtigung zugänglich

The consent forms given to index cases and relatives were different. For the latter, at the time of the investigation, the obligation to inform relatives was not stated in the document.

Arribas-Ayllon M, Featherstone K, Atkinson P (2010) The practical ethics of genetic responsibility: non-disclosure and the autonomy of affect. Soc Theory Health 9(1):3–23. doi:10.1057/sth.2009.22 CrossRef

Barnoy S, Tabak N (2007) Israeli nurses and genetic information disclosure. Nurs Ethics 14(3):280–294. doi:10.1177/0969733007075862 CrossRefPubMed

Bradbury AR, Patrick-Miller L, Egleston BL, Olopade OI, Daly MB, Moore CW, Daugherty CK et al (2012) When parents disclose BRCA1/2 test results: their communication and perceptions of offspring response. Cancer 118(13):3417–3425. doi:10.1002/cncr.26471 CrossRefPubMedPubMedCentral

Bruwer Z, Futter M, Ramesar R (2013) Communicating cancer risk within an African context: experiences, disclosure patterns and uptake rates following genetic testing for Lynch syndrome. Patient Educ Couns 92(1):53–60. doi:10.1016/j.pec.2013.02.001 CrossRefPubMed

Chivers Seymour K, Addington-Hall J, Lucassen AM, Foster CL (2010) What facilitates or impedes family communication following genetic testing for cancer risk? A systematic review and meta-synthesis of primary qualitative research. J Genet Couns 19(4):330–342. doi:10.1007/s10897-010-9296-y CrossRefPubMed

D’Audiffret Van Haecke D, de Montgolfier S (2016) Genetic test results and disclosure to family members: qualitative Interviews of Healthcare Professionals’ Perceptions of Ethical and Professional Issues in France. J Genet Couns 25(3):483–494. doi:10.1007/s10897-015-9896-7 CrossRefPubMed

De Geus E, Aalfs CM, Verdam MGE, de Haes HCJM, Smets EMA (2014) Informing relatives about their hereditary or familial cancer risk: study protocol for a randomized controlled trial. Trials 15:86. doi:10.1186/1745-6215-15-86 CrossRefPubMedPubMedCentral

Dheensa S, Fenwick A, Shkedi-Rafid S, Crawford G, Lucassen A (2016) Health-care professionals’ responsibility to patients’ relatives in genetic medicine: a systematic review and synthesis of empirical research. Genet Med 18:290–301. doi:10.1038/gim.2015.72 (with supplementary table S1 online)CrossRefPubMed

Dugan RB, Wiesner GL, Juengst ET, O’Riordan M, Matthews AL, Robin NH (2003) Duty to warn at-risk relatives for genetic disease: genetic counselors’ clinical experience. Am J Med Genet C Semin Med Genet 119C:27–34CrossRefPubMed

10.

Eeles RA (2000) Future possibilities in the prevention of breast cancer: intervention strategies in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res 2(4):283–290CrossRefPubMedPubMedCentral

11.

Farnos C, Rial-Sebbag E (2013) The genetic information to relatives in 2012, to a patient empowerment for the benefit of his relatives. Presented at the Medical Law Topical Seminar, Les études hospitalières, Bordeaux

12.

Forrest LE, Delatycki MB, Curnow L, Skene L, Aitken M (2010) Genetic health professionals and the communication of genetic information in families: practice during and after a genetic consultation. Am J Med Genet A 152 A(6):1458–1466. doi:10.1002/ajmg.a.33385

13.

Gaff CL, Clarke AJ, Atkinson P, Sivell S, Elwyn G, Iredale R, Edwards A et al (2007) Process and outcome in communication of genetic information within families: a systematic review. Eur J Human Genet 15(10):999–1011. doi:10.1038/sj.ejhg.5201883 CrossRef

14.

Geertz C (1973) The interpretation of cultures: selected essays. Basic Books, New York

15.

Godard B, Hurlimann T, Letendre M, Égalité N (2006) Guidelines for disclosing genetic information to family members: from development to use. Fam Cancer 5(1):103–116. doi:10.1007/s10689-005-2581-5 CrossRefPubMed

16.

Hodgson J, Gaff C (2013) Enhancing family communication about genetics: ethical and professional dilemmas. J Genet Couns 22(1):16–21. doi:10.1007/s10897-012-9514-x CrossRefPubMed

17.

Kardashian A, Fehniger J, Creasman J, Cheung E, Beattie MS (2012) A Pilot study of the sharing risk information tool (ShaRIT) for families with hereditary breast and ovarian cancer syndrome. Hered Cancer Clin Pract 10(1):1–10. doi:10.1186/1897-4287-10-4 CrossRef

18.

Lapointe J, Côté C, Bouchard K, Godard B, Simard J, Dorval M (2013) Life events may contribute to family communication about cancer risk following BRCA1/2 testing. J Genet Couns 22(2):249–257. doi:10.1007/s10897-012-9531-9 CrossRefPubMed

19.

Latour B, Biezunski M (2005) Science in action: how to follow scientists and engineers through society. La Découverte, Paris

20.

Liao SM (2009) Is there a duty to share genetic information? J Med Ethics 35(5):306–309. doi:10.1136/jme.2008.027029 CrossRefPubMed

21.

Law No. 2011–814 dated 7 July 2011 (art. 2) (2011) Code de la santé publique. L1131-1, JORF

22.

McClellan KA, Kleiderman E, Black L, Bouchard K, Dorval M, Simard J, Avard D et al (2013) Exploring resources for intrafamilial communication of cancer genetic risk: we still need to talk. Eur J Hum Genet 21(9):903–910. doi:10.1038/ejhg.2012.286 CrossRefPubMedPubMedCentral

23.

Mendes Á, Paneque M, Sousa L, Clarke A, Sequeiros J (2016) How communication of genetic information within the family is addressed in genetic counselling: a systematic review of research evidence. Eur J Human Genet 24(3):315–325. doi:10.1038/ejhg.2015.174 CrossRef

24.

Parker M, Lucassen AM (2004) Genetic information: a joint account?. BMJ (Clin Res Ed) 329(7458):165–167. doi:10.1136/bmj.329.7458.165 CrossRef

25.

Pujol P, Lyonnet DS, Frebourg T, Blin J, Picot MC, Lasset C, Nogues C et al (2013) Lack of referral for genetic counseling and testing in BRCA1/2 and Lynch syndromes: a nationwide study based on 240,134 consultations and 134,652 genetic tests. Breast Cancer Res Treat 141(1):135–144. doi:10.1007/s10549-013-2669-9 CrossRefPubMed

26.

Schrag D, Kuntz KM, Garber JE, Weeks JC (2000) Benefit of prophylactic mastectomy for women with BRCA1 or BRCA2 mutations. JAMA 283(23):3070–3072CrossRefPubMed

27.

Strauss AL (1987) Qualitative analysis for social scientists. Cambridge University Press, CambridgeCrossRef

28.

Stol YH, Menko FH, Westerman MJ, Janssens RM (2010) Informing family members about a hereditary predisposition to cancer: attitudes and practices among clinical geneticists. J Med Ethics 36:391–395CrossRefPubMed

29.

Suthers GK, Armstrong J, McCormack J, Trott D (2006) Letting the family know: balancing ethics and effectiveness when notifying relatives about genetic testing for a familial disorder. J Med Genet 43(8):665–670

30.

Weil J (2003) Psychosocial genetic counselling in the post non-directive area: a point of view. J Genet Couns 12:199–211CrossRefPubMed

31.

Wilson BJ, Forrest K, van Teijlingen ER, McKee L, Haites N, Matthews E, Simpson SA (2004) Family communication about genetic risk: the little that is known. Commun Genet 7(1):15–24. doi:10.1159/000080300

32.

Wiseman M, Dancyger C, Michie S (2010) Communicating genetic risk information within families: a review. Fam Cancer 9(4):691–703. doi:10.1007/s10689-010-9380-3 CrossRefPubMed

Titel: Supporting disclosure of genetic information to family members: professional practice and timelines in cancer genetics
verfasst von: Benjamin Derbez
Antoine de Pauw
Dominique Stoppa-Lyonnet
Sandrine de Montgolfier
Publikationsdatum: 14.03.2017
Verlag: Springer Netherlands
Erschienen in: Familial Cancer / Ausgabe 3/2017
Print ISSN: 1389-9600
Elektronische ISSN: 1573-7292
DOI: https://doi.org/10.1007/s10689-017-9970-4

Neu im Fachgebiet Onkologie

23.04.2024 | Medikamente in Schwangerschaft und Stillzeit | Nachrichten

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Supporting disclosure of genetic information to family members: professional practice and timelines in cancer genetics

Abstract

Neu im Fachgebiet Onkologie

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Stufenschema weist Prostatakarzinom zuverlässig nach

Update Onkologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2017

Gastric cancer in FAP: a concerning rise in incidence

Correlation between germline mutations in MMR genes and microsatellite instability in ovarian cancer specimens

Baseline results from the UK SIGNIFY study: a whole-body MRI screening study in TP53 mutation carriers and matched controls

ATM mutations for surgeons

Identification of MSH2 inversion of exons 1–7 in clinical evaluation of families with suspected Lynch syndrome

Patients with negative multi-gene panel testing: a back to the future paradox?

Neu im Fachgebiet Onkologie

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Stufenschema weist Prostatakarzinom zuverlässig nach

Update Onkologie